The global percutaneous coronary intervention (PCI) devices market size is expected to reach USD 11.4 billion
by 2027 according to a new study by Polaris Market Research. Coronary artery disease (CAD) is causing most of deaths globally.
The factors contributing to the disease include sedentary lifestyle, smoking,
obesity, hereditary factors and alcohol usage. The mortality rate of CAD has
been tremendously increasing grabbing the attention for researchers and
clinicians globally, With the technological advancements in stent technologies,
design of the guide wires, advent of next generation coronary catheters
(percutaneous transluminal coronary angioplasty (PTCA), percutaneous
transluminal angioplasty (PTA) balloon catheters ), and the availability of
coronary guide wires (steel based, nitinol based ) increased the treatment
scope of the coronary heart diseases.
Polaris Market research has segmented the percutaneous coronary
intervention (PCI) devices market report on the basis of product, end-use and
region
Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-sample
The emergence of dedicated catheterization labs in high income
countries is also pivotal factor influencing the growth of the PCI devices
market. The next generation Cath labs offers advanced services and performs
interventional therapeutic procedures such as PCI, PTCA, epicardial ablations
of ventricular tachycardia, aortic valve replacements and mitral valve repairs.
Additionally, they also perform interventional cardiac electrophysiological
procedures, pacemaker implantation and cardiac defibrillator implantation. The
number of PCI procedures and other cardiac interventions is substantially
increasing with the increase in the cardiovascular diseases globally.
To increase the performance of multi-specialty hospitals, many
government and private hospitals are setting up catheterization labs for
improved service offerings. This concept is gaining popularity for PCI
procedures in Canada, the US, the UK, Germany, and other western countries. The
factors favoring its growth include the conversion of physician’s office to
alternate hospital providers, surgeons’ relationship with the manufacturers to
eliminate the need of general practitioner officers (GPO), and the expansion of
services provided by the hospitals.
Get Exclusive Discount on This Report : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-discount-pricing
Market participants such as Abbott, B. Braun, ASAHI INTECC
Company Limited, Biosensors International Group, Ltd, Boston Scientific
Corporation, C. R. Bard, BIOTRONIK, Comed BV, Cook, Meril Lifesciences, Cordis,
Medtronic PLC, Merit Medical System, and Terumo Corporation are some of the key
players operating in the percutaneous coronary intervention (PCI) devices
market. Key vendors are investing huge amounts into their R&D and
introducing new technologies and launching new products to stay competitive in
this market. Several products were launched in the recent past with the latest
next generation technology which caters the growing needs of the physician and
the patients.
No comments:
Post a Comment
Please do not enter any spam link in the comment box...